相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Michelle Petri et al.
LANCET (2023)
Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry
Katherine A. Owen et al.
SCIENTIFIC REPORTS (2023)
Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE
Erika L. Hubbard et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry
Gloria Yiu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
Melissa Northcott et al.
LUPUS SCIENCE & MEDICINE (2022)
Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study
Xianyong Yin et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
THE IMPACT OF ANTI-SARS-COV-2 VACCINES IN A MULTICENTER COHORT STUDY OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
M. Gerosa et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Distinct transcriptome architectures underlying lupus establishment and exacerbation
Masahiro Nakano et al.
CELL (2022)
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
Andrea R. Daamen et al.
SCIENTIFIC REPORTS (2021)
Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures
Gaia Andreoletti et al.
COMMUNICATIONS BIOLOGY (2021)
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus
Michelle D. Catalina et al.
JCI INSIGHT (2020)
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries
Katherine A. Owen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
Inhibition of IRF5 hyperactivation protects from lupus onset and severity
Su Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
Candice Mazewski et al.
FRONTIERS IN IMMUNOLOGY (2020)
Population genomics of East Asian ethnic groups
Ziqing Pan et al.
HEREDITAS (2020)
Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
Alessia Alunno et al.
CELLS (2019)
Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity
Alfred H. J. Kim et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles
John A. Reynolds et al.
ARTHRITIS RESEARCH & THERAPY (2019)
High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
Vilija Oke et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus
Michelle D. Catalina et al.
COMMUNICATIONS BIOLOGY (2019)
Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus
Adam C. Labonte et al.
PLOS ONE (2018)
Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgrounds
Taro Iwamoto et al.
LUPUS SCIENCE & MEDICINE (2018)
Points to consider for skin ulcers in systemic sclerosis
Felice Galluccio et al.
RHEUMATOLOGY (2017)
High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry
Celi Sun et al.
NATURE GENETICS (2016)
Diagnosis and risk stratification in patients with anti-RNP autoimmunity
M. F. Carpintero et al.
LUPUS (2015)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score
I. Braunstein et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Association of a Functional IRF7 Variant With Systemic Lupus Erythematosus
Qiong Fu et al.
ARTHRITIS AND RHEUMATISM (2011)
Evolutionary genetic dissection of human interferons
Jeremy Manry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus
Silvia N. Kariuki et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus
C. Landolt-Marticorena et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Neutralization of Interferon-alpha/beta-Inducible Genes and Downstream Effect in a Phase I Trial of an Anti-Interferon-alpha Monoclonal Antibody in Systemic Lupus Erythematosus
Yihong Yao et al.
ARTHRITIS AND RHEUMATISM (2009)
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus
M. Petri et al.
LUPUS (2009)
Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity
Ehud Paz et al.
RHEUMATOLOGY INTERNATIONAL (2007)